SUMMARY In a double blind trial of 36 patients with rheumatoid arthritis a new scintimetric method was applied to three comparable patient groups before and after eight months' treatment with levamisole, penicillamine, or azathioprine. Technetium-99m pyrophosphate scintigraphy of both hands was performed on a gammacamera with a computer attached, immediately after the administration of the tracer. The uptake ratio of each proximal interphalangeal (PIP) joint and the mid-half of the adjacent proximal phalanx was calculated from the activity counted for one minute. A scintimetric index was expressed as the sum of eight uptake ratios. This index was higher for each of the three patient groups before start of treatment than that for 10 age matched controls. After eight months of treatment the index, the number of PIP joints with clinical signs of synovitis, and the total circumference of the PIP joints decreased in the penicillamine and azathioprine groups. The scintimetric method reliably reflected local synovitis activity and its changes but, like grip strength and PIP circumference, was not a representative measure of the overall activity of the disease.
Clinical assessment of synovitis activity in patients with rheumatoid arthritis (RA) is difficult. Joint scanning by means of radioisotopes, which is one of several alternative methods of measuring synovitis activity, has been used with varying success for more than 20 years.1
Scintimetric assessments of the response of treatment with disease modifying antirheumatic drugs (DMARDs) have been attempted previously in a few open trials.2 3 In the present study a new scintimetric method was evaluated. Repeated quantitative joint scintigraphies were performed in a controlled, double blind, comparative trial of levamisole, penicillamine, and azathioprine given to patients with RA and active synovitis. The results of the scintimetries were compared with serial clinical, biochemical, and radiological measurements of synovitis activity and the progression of structural joint damage assessed radiologically. At the same Accepted for publication 19 April 1988. Correspondence to Dr Niels Olsen, Frydendalsvej 1, DK-1809 Frederiksberg C, Denmark. time joint scintimetries were performed in a group of age matched controls.
Subjects and methods
Fifty nine patients who entered the study fulfilled the criteria of the American Rheumatism Association for the diagnosis of RA,4 as well as at least three of the following four criteria for active synovitis5: (a) three or more swollen joints; (b) six or more tender joints; (c) morning stiffness of at least 45 minutes' duration; (d) erythrocyte sedimentation rate (ESR) of at least 30 mm/h. The exclusion criteria were as follows: functional class IV6; age of 16 years or less; pregnancy or intention to become pregnant; concurrent diseases with poor prognosis as far as life is concerned; and treatment with levamisole, penicillamine, azathioprine, chloroquine, gold salts, cyclophosphamide, or glucocorticoids within the past three months. Ten age matched controls had joint scintigraphy performed because of fractured femoral necks. None of them had a history of joint disease or clinical signs of joint 995 abnormalities in their hands. All patients and controls gave informed consent to the study, which was approved by the local ethical committee.
The controlled study of the effect of levamisole (150 mg daily), penicillamine (600 mg daily), and azathioprine (2.5 mg/kg daily) was designed as a controlled, comparative, double blind study of eight months' duration with an open therapeutic control, as previously described.7 Ibuprofen was the only non-steroidal anti-inflammatory drug permitted. The patients were allocated to treatment with one of the three DMARDs by means of a 'minimisation technique'.8 Table 1 lists the patients on whom joint scintigraphy was performed, and Table 2 gives their characteristics at the start of the trial. The patients were examined before the start of treatment with DMARDs (month 0) and after eight months of treatment (month 8 
Results
The reproducibility of the uptake ratio, expressed as 1 SD in percentage of average scintimetric ratio, was 10%. Similarly, the reproducibility of the total index was 4%. Table 3 shows that the index values were significantly higher at month 0 in each of the three treatment groups than in the control group. After II II II II II III II III III II  I III III f I III III I group Table 3 Isotope 'activity' index ofthe eight ulnar PIP joints before (month 0) and after (month 8) treatment tSignificantly different from controls (p<005).
tSignificant change during treatment (p<002).
No significant differences between the treatment groups (p>O-OS).
eight months of treatment the index decreased significantly in the penicillamine and azathioprine groups, but the decrease was not significant in the group receiving levamisole. Table 4 shows the average clinical, laboratory, and radiological variables of the three treatment groups. The number of swollen and tender PIP joints and the circumference of the PIP joints decreased in the penicillamine and azathioprine groups, but the decrease was not significant in the group receiving levamisole. The grip strength improved in the azathioprine group only, but the total number of swollen joints, the duration of morning stiffness, joint pain, ESR, and serum albumin improved significantly in all three groups. The deterioration of the radiological changes during treatment was not significant in any of the three treatment groups.
No significant correlations were found between the changes during the treatment period of the scintimetric index and the clinical, laboratory, or radiological changes (rs<025, p>O10, n=36). The best numerical correlations (p<O0O1, n=36) between the changes during the treatment period of the variables of Table 4 were tender and swollen PIP joints versus grip strength (rs= -0.47), morning stiffness versus joint pain (rs=0.51), and ESR versus serum albumin (rs=-0.46). Table 5 shows that the scintimetric ratio of single, swollen PIP joints significantly exceeded that of tender PIP joints without swelling. On the other hand, the scintimetric ratios of clinically normal PIP joints of patients with RA and of controls were significantly lower than those of tender PIP joints without swelling. The scintimetric ratios of clinically normal joints from patients with RA and from controls did not differ. Table 6 shows that significant correlations existed between the changes of the clinical abnormalities of single PIP joints during the treatment period and the changes of the scintimetric ratios during the same interval.
Discussion
The scintimetric procedure in the present study was designed to combine the best properties of the methods used previously. The PIP joints, because of their anatomy, are particularly well suited for quantitative scintigraphy, and as these joints are often affected in patients with RA the present study was limited to them. The synovitis activity of swollen or tender but not swollen PIP joints and its changes during the treatment period were objectively and reliably measured by the present scintimetric uptake ratio. Such a quantitative measurement of synovitis activity of single joints is not obtainable from radiograms or measurements of grip strength or PIP circumference. Therefore the scintimetric ratio may be of help in the evaluation of local synovitis activity and its changes during treatment as the clinical evaluation is qualitative and may be influenced by wide ranges of interobserver variations. As might have been expected from the clinical picture of RA no statistically significant correlation was found between the present scintimetric index of the PIP joints and the clinical signs of synovitis activity in all the accessible joints of the body. Neither did the change of clinical synovitis activity of the PIP joints, the PIP circumference, or the grip strength reflect the clinical change of synovitis activity of all joints. Thus a clinically useful method of monitoring the overall effect of treatment modalities should preferably be able to include all accessible joints. Application of the principles of the present scintimetric ratio to all scintigraphically suspected joints of the body may provide more useful information. 
